Aclaris Therapeutics
ACRS
ACRS
109 hedge funds and large institutions have $1.02B invested in Aclaris Therapeutics in 2022 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 37 increasing their positions, 43 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
14% less repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 43
18% less funds holding
Funds holding: 133 → 109 (-24)
68% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 31
Holders
109
Holding in Top 10
9
Calls
$1.15M
Puts
$217K
Top Buyers
| 1 | +$39.3M | |
| 2 | +$31.3M | |
| 3 | +$28.2M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$20.9M |
| 5 |
O
OrbiMed
New York
|
+$10.2M |
Top Sellers
| 1 | -$13.1M | |
| 2 | -$8.62M | |
| 3 | -$8.19M | |
| 4 |
PA
Perceptive Advisors
New York
|
-$6.86M |
| 5 |
CC
Commodore Capital
New York
|
-$6.17M |